← Back to Search

Standard cardiac imaging (SPECT) for Heart Failure (AIMI-HF Trial)

N/A
Waitlist Available
Led By Lisa Mielniczuk, MD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 12, 24 months
Awards & highlights

AIMI-HF Trial Summary

This trial will compare the effect of different heart failure imaging strategies on clinical outcomes and decision making in patients with HF.

Eligible Conditions
  • Heart Failure
  • Cardiomyopathy
  • Coronary Artery Disease

AIMI-HF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 12, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 12, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The time to event of the composite clinical endpoint.
Secondary outcome measures
Cardiac biomarkers change over time
Event rates between advanced and standard modalities
HF symptoms between advanced and standard modalities
+11 more
Other outcome measures
Cost-effectiveness economic analysis of advances vs standard modalities
Safety Analysis between advanced and standard modalities

AIMI-HF Trial Design

2Treatment groups
Active Control
Group I: Standard cardiac imaging (SPECT)Active Control1 Intervention
Patients will undergo standard cardiac imaging procedures for evaluation of heart failure such as single photon emission computed tomography (SPECT).
Group II: Advanced cardiac imaging (PET/CT or CMR)Active Control1 Intervention
Patients will undergo cardiac imaging as evaluation of heart failure using 1 of the following alternate/advanced imaging modalities: Positron Emission Tomography (PET/CT), Cardiac Magnetic Resonance (CMR)

Find a Location

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
188 Previous Clinical Trials
91,046 Total Patients Enrolled
18 Trials studying Heart Failure
9,754 Patients Enrolled for Heart Failure
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,452,377 Total Patients Enrolled
29 Trials studying Heart Failure
2,876,291 Patients Enrolled for Heart Failure
The Finnish Funding Agency for Technology and Innovation (TEKES)OTHER_GOV
15 Previous Clinical Trials
16,854 Total Patients Enrolled
2 Trials studying Heart Failure
771 Patients Enrolled for Heart Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)
Rob Beanlands 2011. "IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01288560.
~98 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top